A phase 2a randomized controlled study to evaluate the pharmacokinetic, safety, tolerability and clinical effect of topically applied Umeclidinium in subjects with primary axillary hyperhidrosis
2017 ◽
Vol 32
(1)
◽
pp. 145-151
◽
2008 ◽
Vol 2008
◽
pp. 421-422
1999 ◽
Vol 31
(2)
◽
pp. 101-107
◽
Keyword(s):